“…Part of the dose is converted by cyctoplasmic NADPH‐dependent aldoketoreductase to a cytotoxic 13‐hydroxyl metabolite, doxorubicinol, which circulates in appreciable concentrations in mammals (Speth et al. , 1988), and birds (Gilbert et al. , 2004; Gilbert, 2004), and which is suspected to be responsible for cardiotoxicity seen in some human patients given doxorubicin (Olsen et al.…”